Impact of preoperative treatment on the CINSARC prognostic signature: translational research results from a phase 1 trial of the German Interdisciplinary Sarcoma Group (GISG 03)

go back to reference Casali PG, Abecassis N, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee J, Brodowicz T, Broto JM, Buonadonna A, De Alava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hannu A, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krakorova DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schoffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, Van der Graaf W, Whelan J, Wardelmann E, Zaikova O, Blay JY (2018) Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Suppl 4):iv67–iv51. https://doi.org/10.1093/annonc/mdy096 CrossRef Casali PG, Abecassis N, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee J, Brodowicz T, Broto JM, Buonadonna A, De Alava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hannu A, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krakorova DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schoffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, Van der Graaf W, Whelan J, Wardelmann E, Zaikova O, Blay JY (2018) Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Suppl 4):iv67–iv51. https://​doi.​org/​10.​1093/​annonc/​mdy096 CrossRef

go back to reference von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM 3rd, Keedy V, Kim E, Koon H, Mayerson J, McCarter M, McGarry SV, Meyer C, Morris ZS, O’Donnell RJ, Pappo AS, Paz IB, Petersen IA, Pfeifer JD, Riedel RF, Ruo B, Schuetze S, Tap WD, Wayne JD, Bergman MA, Scavone JL (2018) Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 16(5):536–563. https://doi.org/10.6004/jnccn.2018.0025 CrossRef von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM 3rd, Keedy V, Kim E, Koon H, Mayerson J, McCarter M, McGarry SV, Meyer C, Morris ZS, O’Donnell RJ, Pappo AS, Paz IB, Petersen IA, Pfeifer JD, Riedel RF, Ruo B, Schuetze S, Tap WD, Wayne JD, Bergman MA, Scavone JL (2018) Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 16(5):536–563. https://​doi.​org/​10.​6004/​jnccn.​2018.​0025 CrossRef

go back to reference Kirste S, Landenberger N, Scholber J, Henne K, Wittel UA, Grosu AL (2019) Retroperitoneal soft tissue sarcoma: low-dose neoadjuvant radiation therapy followed by surgery with or without intraoperative radiotherapy and adjuvant radiation therapy. Strahlenther Onkol 195(6):558–565. https://doi.org/10.1007/s00066-019-01464-3 CrossRefPubMed Kirste S, Landenberger N, Scholber J, Henne K, Wittel UA, Grosu AL (2019) Retroperitoneal soft tissue sarcoma: low-dose neoadjuvant radiation therapy followed by surgery with or without intraoperative radiotherapy and adjuvant radiation therapy. Strahlenther Onkol 195(6):558–565. https://​doi.​org/​10.​1007/​s00066-019-01464-3 CrossRefPubMed

go back to reference Woll PJ, Reichardt P, Le Cesne A, Bonvalot S, Azzarelli A, Hoekstra HJ, Leahy M, Van Coevorden F, Verweij J, Hogendoorn PC, Ouali M, Marreaud S, Bramwell VH, Hohenberger P, EORTC Soft Tissue and Bone Sarcoma Group, NCIC Clinical Trials Group Sarcoma Disease Site Committee (2012) Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol 13(10):1045–1054. https://doi.org/10.1016/S1470-2045(12)70346-7 CrossRefPubMed Woll PJ, Reichardt P, Le Cesne A, Bonvalot S, Azzarelli A, Hoekstra HJ, Leahy M, Van Coevorden F, Verweij J, Hogendoorn PC, Ouali M, Marreaud S, Bramwell VH, Hohenberger P, EORTC Soft Tissue and Bone Sarcoma Group, NCIC Clinical Trials Group Sarcoma Disease Site Committee (2012) Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol 13(10):1045–1054. https://​doi.​org/​10.​1016/​S1470-2045(12)70346-7 CrossRefPubMed

go back to reference Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M (2008) A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 113(3):573–581. https://doi.org/10.1002/cncr.23592 CrossRefPubMed Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M (2008) A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 113(3):573–581. https://​doi.​org/​10.​1002/​cncr.​23592 CrossRefPubMed

go back to reference Chibon F, Lagarde P, Salas S, Perot G, Brouste V, Tirode F, Lucchesi C, de Reynies A, Kauffmann A, Bui B, Terrier P, Bonvalot S, Le Cesne A, Vince-Ranchere D, Blay JY, Collin F, Guillou L, Leroux A, Coindre JM, Aurias A (2010) Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nat Med 16(7):781–787. https://doi.org/10.1038/nm.2174 CrossRefPubMed Chibon F, Lagarde P, Salas S, Perot G, Brouste V, Tirode F, Lucchesi C, de Reynies A, Kauffmann A, Bui B, Terrier P, Bonvalot S, Le Cesne A, Vince-Ranchere D, Blay JY, Collin F, Guillou L, Leroux A, Coindre JM, Aurias A (2010) Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity. Nat Med 16(7):781–787. https://​doi.​org/​10.​1038/​nm.​2174 CrossRefPubMed

go back to reference Italiano A, Lagarde P, Brulard C, Terrier P, Lae M, Marques B, Ranchere-Vince D, Michels JJ, Trassard M, Cioffi A, Piperno-Neumann S, Chevreau C, Blay JY, Delcambre C, Isambert N, Penel N, Bay JO, Bonvalot S, Le Cesne A, Coindre JM, Chibon F (2013) Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics. Clin Cancer Res 19(5):1190–1196. https://doi.org/10.1158/1078-0432.ccr-12-2970 CrossRefPubMed Italiano A, Lagarde P, Brulard C, Terrier P, Lae M, Marques B, Ranchere-Vince D, Michels JJ, Trassard M, Cioffi A, Piperno-Neumann S, Chevreau C, Blay JY, Delcambre C, Isambert N, Penel N, Bay JO, Bonvalot S, Le Cesne A, Coindre JM, Chibon F (2013) Genetic profiling identifies two classes of soft-tissue leiomyosarcomas with distinct clinical characteristics. Clin Cancer Res 19(5):1190–1196. https://​doi.​org/​10.​1158/​1078-0432.​ccr-12-2970 CrossRefPubMed

go back to reference Le Guellec S, Lesluyes T, Sarot E, Valle C, Filleron T, Rochaix P, Valentin T, Perot G, Coindre JM, Chibon F (2018) Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas. Ann Oncol 29(8):1828–1835. https://doi.org/10.1093/annonc/mdy194 CrossRefPubMed Le Guellec S, Lesluyes T, Sarot E, Valle C, Filleron T, Rochaix P, Valentin T, Perot G, Coindre JM, Chibon F (2018) Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas. Ann Oncol 29(8):1828–1835. https://​doi.​org/​10.​1093/​annonc/​mdy194 CrossRefPubMed

go back to reference Chibon F, Lesluyes T, Valentin T, Le Guellec S (2019) CINSARC signature as a prognostic marker for clinical outcome in sarcomas and beyond. Genes 58(2):124–129. https://doi.org/10.1002/gcc.22703 CrossRef Chibon F, Lesluyes T, Valentin T, Le Guellec S (2019) CINSARC signature as a prognostic marker for clinical outcome in sarcomas and beyond. Genes 58(2):124–129. https://​doi.​org/​10.​1002/​gcc.​22703 CrossRef

go back to reference Kroeze SGC, Fritz C, Basler L, Gkika E, Brunner TB, Grosu AL, Guckenberger M (2019) Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries. Strahlenther Onkol 195(3):199–206. https://doi.org/10.1007/s00066-018-01422-5 CrossRefPubMed Kroeze SGC, Fritz C, Basler L, Gkika E, Brunner TB, Grosu AL, Guckenberger M (2019) Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries. Strahlenther Onkol 195(3):199–206. https://​doi.​org/​10.​1007/​s00066-018-01422-5 CrossRefPubMed

go back to reference Jakob J, Rauch G, Wenz F, Hohenberger P (2013) Phase I trial of concurrent sunitinib and radiation therapy as preoperative treatment for soft tissue sarcoma. BMJ Open 3(9):e3626. https://doi.org/10.1136/bmjopen-2013-003626 CrossRefPubMedPubMedCentral Jakob J, Rauch G, Wenz F, Hohenberger P (2013) Phase I trial of concurrent sunitinib and radiation therapy as preoperative treatment for soft tissue sarcoma. BMJ Open 3(9):e3626. https://​doi.​org/​10.​1136/​bmjopen-2013-003626 CrossRefPubMedPubMedCentral

go back to reference Jakob J, Simeonova A, Kasper B, Ronellenfitsch U, Wenz F, Hohenberger P (2015) Combined radiation therapy and sunitinib for preoperative treatment of soft tissue sarcoma. Ann Surg Oncol 22(9):2839–2845. https://doi.org/10.1245/s10434-015-4680-3 CrossRefPubMed Jakob J, Simeonova A, Kasper B, Ronellenfitsch U, Wenz F, Hohenberger P (2015) Combined radiation therapy and sunitinib for preoperative treatment of soft tissue sarcoma. Ann Surg Oncol 22(9):2839–2845. https://​doi.​org/​10.​1245/​s10434-015-4680-3 CrossRefPubMed

go back to reference Jakob J, Simeonova A, Kasper B, Ronellenfitsch U, Rauch G, Wenz F, Hohenberger P (2016) Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03). Radiat Oncol 11:77. https://doi.org/10.1186/s13014-016-0654-2 CrossRefPubMedPubMedCentral Jakob J, Simeonova A, Kasper B, Ronellenfitsch U, Rauch G, Wenz F, Hohenberger P (2016) Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03). Radiat Oncol 11:77. https://​doi.​org/​10.​1186/​s13014-016-0654-2 CrossRefPubMedPubMedCentral

go back to reference Datta K, Hyduke DR, Suman S, Moon BH, Johnson MD, Fornace AJ Jr. (2012) Exposure to ionizing radiation induced persistent gene expression changes in mouse mammary gland. Radiat Oncol 7:205. https://doi.org/10.1186/1748-717x-7-205 CrossRefPubMedPubMedCentral Datta K, Hyduke DR, Suman S, Moon BH, Johnson MD, Fornace AJ Jr. (2012) Exposure to ionizing radiation induced persistent gene expression changes in mouse mammary gland. Radiat Oncol 7:205. https://​doi.​org/​10.​1186/​1748-717x-7-205 CrossRefPubMedPubMedCentral

go back to reference Smyth EC, Nyamundanda G, Cunningham D, Fontana E, Ragulan C, Tan IB, Lin SJ, Wotherspoon A, Nankivell M, Fassan M, Lampis A, Hahne JC, Davies AR, Lagergren J, Gossage JA, Maisey N, Green M, Zylstra JL, Allum WH, Langley RE, Tan P, Valeri N, Sadanandam A (2018) A seven-gene signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial. Ann Oncol 29(12):2356–2362. https://doi.org/10.1093/annonc/mdy407 CrossRefPubMedPubMedCentral Smyth EC, Nyamundanda G, Cunningham D, Fontana E, Ragulan C, Tan IB, Lin SJ, Wotherspoon A, Nankivell M, Fassan M, Lampis A, Hahne JC, Davies AR, Lagergren J, Gossage JA, Maisey N, Green M, Zylstra JL, Allum WH, Langley RE, Tan P, Valeri N, Sadanandam A (2018) A seven-gene signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial. Ann Oncol 29(12):2356–2362. https://​doi.​org/​10.​1093/​annonc/​mdy407 CrossRefPubMedPubMedCentral

go back to reference Pasquali S, Pizzamiglio S, Touati N, Litiere S, Marreaud S, Kasper B, Gelderblom H, Stacchiotti S, Judson I, Dei Tos AP, Verderio P, Casali PG, Woll PJ, Gronchi A (2019) The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial. Eur J Cancer 109:51–60. https://doi.org/10.1016/j.ejca .2018.12.009CrossRef Pasquali S, Pizzamiglio S, Touati N, Litiere S, Marreaud S, Kasper B, Gelderblom H, Stacchiotti S, Judson I, Dei Tos AP, Verderio P, Casali PG, Woll PJ, Gronchi A (2019) The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial. Eur J Cancer 109:51–60. https://​doi.​org/​10.​1016/​j.​ejca .2018.12.009CrossRef

go back to reference Peeken JC, Goldberg T, Knie C, Komboz B, Bernhofer M, Pasa F, Kessel KA, Tafti PD, Rost B, Nusslin F, Braun AE, Combs SE (2018) Treatment-related features improve machine learning prediction of prognosis in soft tissue sarcoma patients. Strahlenther Onkol 194(9):824–834. https://doi.org/10.1007/s00066-018-1294-2 CrossRefPubMed Peeken JC, Goldberg T, Knie C, Komboz B, Bernhofer M, Pasa F, Kessel KA, Tafti PD, Rost B, Nusslin F, Braun AE, Combs SE (2018) Treatment-related features improve machine learning prediction of prognosis in soft tissue sarcoma patients. Strahlenther Onkol 194(9):824–834. https://​doi.​org/​10.​1007/​s00066-018-1294-2 CrossRefPubMed